Clinical Trial Update: Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI [NA]

View source ↗

Summary

A completed clinical trial evaluating whether microvascular resistance measured by IMR can predict cumulative outcomes in STEMI patients undergoing primary PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multivessel Coronary Artery Disease
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• PressureWire (pressure wire)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Multi Vessel Coronary Artery Disease, STEMI | NA | Status: COMPLETED | Results posted: 2025-08-08